Patient with MF with transformed disease. (A) On limbs. (B) On trunk. (C) OS of patients with advanced-stage disease according to the presence (n = 22) or absence (n = 70) of large-cell transformation in the advanced-stage population.⁹  Median OS in the transformed group was 2.2 years, compared with 5.2 years in the nontransformed group.